<i>Candidiasis</i> and Mechanisms of Antifungal Resistance

<i>Candidiasis</i> can be present as a cutaneous, mucosal or deep-seated organ infection, which is caused by more than 20 types of <i>Candida</i> sp., with <i>C. albicans</i> being the most common. These are pathogenic yeast and are usually present in the normal m...

Full description

Bibliographic Details
Main Authors: Somanon Bhattacharya, Sutthichai Sae-Tia, Bettina C. Fries
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/9/6/312
_version_ 1797565716995506176
author Somanon Bhattacharya
Sutthichai Sae-Tia
Bettina C. Fries
author_facet Somanon Bhattacharya
Sutthichai Sae-Tia
Bettina C. Fries
author_sort Somanon Bhattacharya
collection DOAJ
description <i>Candidiasis</i> can be present as a cutaneous, mucosal or deep-seated organ infection, which is caused by more than 20 types of <i>Candida</i> sp., with <i>C. albicans</i> being the most common. These are pathogenic yeast and are usually present in the normal microbiome. High-risk individuals are patients of human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS), organ transplant, and diabetes. During infection, pathogens can adhere to complement receptors and various extracellular matrix proteins in the oral and vaginal cavity. Oral and vaginal <i>Candidiasis</i> results from the overgrowth of <i>Candida</i> sp. in the hosts, causing penetration of the oral and vaginal tissues. Symptoms include white patches in the mouth, tongue, throat, and itchiness or burning of genitalia. Diagnosis involves visual examination, microscopic analysis, or culturing. These infections are treated with a variety of antifungals that target different biosynthetic pathways of the pathogen. For example, echinochandins target cell wall biosynthesis, while allylamines, azoles, and morpholines target ergosterol biosynthesis, and 5-Flucytosine (5FC) targets nucleic acid biosynthesis. Azoles are commonly used in therapeutics, however, because of its fungistatic nature, <i>Candida</i> sp. evolve azole resistance. Besides azoles, <i>Candida</i> sp. also acquire resistance to polyenes, echinochandins, and 5FC. This review discusses, in detail, the drug resistance mechanisms adapted by <i>Candida</i> sp.
first_indexed 2024-03-10T19:16:57Z
format Article
id doaj.art-671e0fc5c11e4e2fb2c20bccf091738e
institution Directory Open Access Journal
issn 2079-6382
language English
last_indexed 2024-03-10T19:16:57Z
publishDate 2020-06-01
publisher MDPI AG
record_format Article
series Antibiotics
spelling doaj.art-671e0fc5c11e4e2fb2c20bccf091738e2023-11-20T03:17:58ZengMDPI AGAntibiotics2079-63822020-06-019631210.3390/antibiotics9060312<i>Candidiasis</i> and Mechanisms of Antifungal ResistanceSomanon Bhattacharya0Sutthichai Sae-Tia1Bettina C. Fries2Division of Infectious Diseases, Department of Medicine, Stony Brook University, Stony Brook, New York, NY 11794, USADivision of Infectious Diseases, Department of Medicine, Stony Brook University, Stony Brook, New York, NY 11794, USADivision of Infectious Diseases, Department of Medicine, Stony Brook University, Stony Brook, New York, NY 11794, USA<i>Candidiasis</i> can be present as a cutaneous, mucosal or deep-seated organ infection, which is caused by more than 20 types of <i>Candida</i> sp., with <i>C. albicans</i> being the most common. These are pathogenic yeast and are usually present in the normal microbiome. High-risk individuals are patients of human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS), organ transplant, and diabetes. During infection, pathogens can adhere to complement receptors and various extracellular matrix proteins in the oral and vaginal cavity. Oral and vaginal <i>Candidiasis</i> results from the overgrowth of <i>Candida</i> sp. in the hosts, causing penetration of the oral and vaginal tissues. Symptoms include white patches in the mouth, tongue, throat, and itchiness or burning of genitalia. Diagnosis involves visual examination, microscopic analysis, or culturing. These infections are treated with a variety of antifungals that target different biosynthetic pathways of the pathogen. For example, echinochandins target cell wall biosynthesis, while allylamines, azoles, and morpholines target ergosterol biosynthesis, and 5-Flucytosine (5FC) targets nucleic acid biosynthesis. Azoles are commonly used in therapeutics, however, because of its fungistatic nature, <i>Candida</i> sp. evolve azole resistance. Besides azoles, <i>Candida</i> sp. also acquire resistance to polyenes, echinochandins, and 5FC. This review discusses, in detail, the drug resistance mechanisms adapted by <i>Candida</i> sp.https://www.mdpi.com/2079-6382/9/6/312candidiasisantifungal resistanceazole resistanceefflux pumpergosterol biosynthesisechinochandin resistance
spellingShingle Somanon Bhattacharya
Sutthichai Sae-Tia
Bettina C. Fries
<i>Candidiasis</i> and Mechanisms of Antifungal Resistance
Antibiotics
candidiasis
antifungal resistance
azole resistance
efflux pump
ergosterol biosynthesis
echinochandin resistance
title <i>Candidiasis</i> and Mechanisms of Antifungal Resistance
title_full <i>Candidiasis</i> and Mechanisms of Antifungal Resistance
title_fullStr <i>Candidiasis</i> and Mechanisms of Antifungal Resistance
title_full_unstemmed <i>Candidiasis</i> and Mechanisms of Antifungal Resistance
title_short <i>Candidiasis</i> and Mechanisms of Antifungal Resistance
title_sort i candidiasis i and mechanisms of antifungal resistance
topic candidiasis
antifungal resistance
azole resistance
efflux pump
ergosterol biosynthesis
echinochandin resistance
url https://www.mdpi.com/2079-6382/9/6/312
work_keys_str_mv AT somanonbhattacharya icandidiasisiandmechanismsofantifungalresistance
AT sutthichaisaetia icandidiasisiandmechanismsofantifungalresistance
AT bettinacfries icandidiasisiandmechanismsofantifungalresistance